Passage Bio Inc (PASG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -64,767 | -102,062 | -136,125 | -185,386 | -112,232 |
| Depreciation Amortization | 1,554 | 1,685 | 4,452 | 4,321 | 1,433 |
| Accounts payable and accrued liabilities | -556 | -2,790 | -5,412 | 2,201 | 4,588 |
| Other Working Capital | 4,204 | 5,339 | -8,491 | 11,420 | 14,440 |
| Other Operating Activity | 11,609 | 19,564 | 27,366 | 40,565 | 11,251 |
| Operating Cash Flow | $-47,956 | $-78,264 | $-118,210 | $-126,879 | $-80,520 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 54,980 | 65,383 | 30,473 | -20,172 | -170,460 |
| PPE Investments | -34 | -146 | -2,274 | -17,642 | -1,146 |
| Purchase Sale Intangibles | N/A | N/A | -3,000 | -8,000 | -500 |
| Other Investing Activity | 0 | 0 | -3,000 | -8,000 | -500 |
| Investing Cash Flow | $54,946 | $65,237 | $25,199 | $-45,814 | $-172,106 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,874 | 135 | 433 | 166,994 | 228,754 |
| Other Financing Activity | 0 | 0 | -1,786 | -338 | 0 |
| Financing Cash Flow | $8,874 | $135 | $-1,353 | $166,656 | $228,754 |
| Beginning Cash Position | 21,709 | 34,601 | 128,965 | 135,002 | 158,874 |
| End Cash Position | 37,573 | 21,709 | 34,601 | 128,965 | 135,002 |
| Net Cash Flow | $15,864 | $-12,892 | $-94,364 | $-6,037 | $-23,872 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,956 | -78,264 | -118,210 | -126,879 | -80,520 |
| Capital Expenditure | -34 | -146 | -2,274 | -17,642 | -1,146 |
| Free Cash Flow | -47,990 | -78,410 | -120,484 | -144,521 | -81,666 |